| Message: | Product Description:
1.Methenolone Acetate is void of the typical C17-alpha alkylation common in nearly all oral anabolic steroids, and therefore Primobolan presents no measurable hepatotoxic effects on the body. Oral Primobolan has failed to demonstrate any changes in liver enzyme values that would be cause for concern. Primobolan in particular does possess in its own right a resistance to hepatic metabolism and breakdown, and only one incidence of a death resultant of hepatotoxicity and liver failure from oral Primobolan has been recorded in one male elderly individual who was prescribed the compound for the purpose of treating anemia. Methenolone Acetate is the injectable version of the steroid methenolone powders. It is the same compound as the one in Primobolan Orals (methenolone acetate), both produced by Schering. In this injectable version, an enanthate ester is added to the steroid, which makes for a slow and gradual release from the site of injection. Its length of activity would thus be quite similar to Testosterone enanthate, with blood levels remaining elevated for approximately two weeks.
2.Methenolone Acetate is a brand name for the anabolic steroid methenolone acetate. This agent is very similar in action to Primobolan® Depot, except here the drug is designed for oral administration instead of injection. Methenolone acetate is a non-c17-alpha-alkylated oral steroid, one of only a few commercially available oral agents that presents limited liver toxicity to the user. It is also highly favored for its properties as a moderately effective anabolic with low androgenic and no estrogenic properties. It is, likewise, commonly used during cutting phases of training, when lean tissue growth and solid muscularity, not raw bulk, are the key objectives.
|
my account
